PAO Group, Inc. Takes on Opioid Crisis with Free Naloxon Classes for the Public; Announces Lease Agreement LOIs for State Approved Medical Cannabis Dispensaries alongside Positive 3rd Quarter Financials
SANDUSKY, Ohio, Nov. 21, 2017 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC:PAOG), a physicians practice management company focused on the proper use of cannabis for treatment of chronic and terminal patients, announces today that, in partnership with its sister company, Rising BioSciences, Inc. (OTC:RSII), it will be holding classes in its Ohio facilities for the general public that focus on proper usage for Naloxone.
Naloxone is a medication designed to rapidly reverse opioid overdose and is often sold under trade names Narcan® and Evzio®. Classes will be held in the Company’s Sandusky, Toledo, and Parma locations. In collaboration with Rising Biosciences, PAO Group's Alternative Medicine Centers will make Naloxone available at little to no cost for the people that participate in the events.
“In line with our core mission, PAO Group and its associates are doing everything we can to implement responsible use of Cannabis and innovative medicine to mitigate the grip that opiates currently have on our country,” states Christopher Will, Vice President of Operations. “The classes are something we’ve added to educate the community while further raising awareness of the opioid epidemic affecting so many Americans and their loved ones.”
In addition to the Naloxone classes, PAO is thrilled to announce that it has received Letters of Intent from two (2) of the applicants for the thirty (30) state approved cannabis dispensaries in the State of Ohio, to lease buildings from PAO Group, Inc. for operations.
“We continue to grow the company with an assertive strategy designed to put the patients first,” states Will. “We have posted 3rd Quarter filings with OTC Markets and are very pleased with the continued success. This quarter saw close to $200,000 in revenues, and we expect cumulative increase in revenues as we continue to expand our facilities and offerings.”
Dates and Times for the Naloxone classes will be announced via press release and social media channels once confirmed.
Visit our website at: www.PAO.Group
Contact us: email@example.com or 1-888-PAO-Group "Like" and "Share"
PAO Group on Facebook/paogroupinc and follow us on Twitter @paogroup
Alternative Medicine Centers of America provides health education, lifestyle coaching, and naturopathic medicine essential to an individual's successful achievement of personal wellness. Our success comes from providing patients with safe and confidential access to quality alternative healthcare, while providing them with the most professional support systems available. Alternative Medicine Centers of America provides the community and patient with the most current, innovative and dynamic wellness information and services possible. Alternative Medicine Centers of America brings to light personal wellness potential for patients and facilitates their journey to harmonious fitness.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
Copyright © 2017 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.